Neuroscience R&D Technologies Conference
Barcelona, ES
Attendance type(s): In Person
Event Dates: 03—4 Dec 2015
Revolutionary innovations make neuroscience the most exciting field of research in modern day science. Understanding functions of the brain and how it works are the fastest developing areas having implications for treatments of life altering neurological and psychiatric illnesses.
The number of drugs developed by big pharma for brain and CNS disorders have gone down in the last five years; but technological advances have reversed this trend. In the last financial year, massive investments have come back in both drug development as well as non-invasive therapies like neuromodulation and deep brain stimulation. Advances in modern brain imaging, neuroinformatics and animal models have been discussed at length but how can they be applied to screen and validate compounds, devices and other treatments at an early developmental stage?
Key focus areas include:
Neuroinformatics for brain research models
Computational disease drug response models
Imaging technologies for early go/no-go decisions
Translational animal models
Neuromodulation & Deep Brain Stimulation
Patient Stratification & advanced brain monitoring
Serious games and virtual reality
Investing & partnering in neurotechnology
Key Speakers :
Anirvan Ghosh, Vice President, Global Head, Neuroscience Discovery & Biomarkers, Roche
Eric Karran, Director Research Strategy, Alzheimers UK
Marc-Oliver Gewaltig, Co-director Neurorobotics, Human Brain Project
Jan Torleif Pedersen, Director, Lead Specialist, H. Lundbeck
Van Weeden, Director of Connectomics, Martinos Center
Philip Szekeres, Director Neuroscience, Eli Lilly
Marcus Kaiser, Associate Professor in Neuroinformatics, Newcastle University
Michael Ahlijanian, Director, Bristol-Myers Squib
Simon Schultz, Director, Center of Neurotechnology, Imperial College of London
Rafal Kamisnki, Senior Director neuroscience TA, UCB Biopharma
Contact Details
Email: info@mnmconferences.com